I disagree with you on this one. Neuren made an excellent deal.
"The two companies will jointly share global research, development and commercialization responsibilities and share 50/50 in all worldwide costs and future profits." <- Neuren has the ROW rights for Trof which equals more income than the 60 million upfront payment and potential milestone payments of up to $907 million and royalties on future sales
I personally think Acadia learned its lesson from the deal they made with NEU and secure them more rights in future deals which they have achieved. Plus they have secured a 2nd compound (the undisclosed one), which again they didnt do with Neuren. Otherwise they would have aimed at NZZ 2591 already.
my opinion only ...
- Forums
- ASX - By Stock
- NEU
- ACADIA PARTNERSHIP STOKE THERAPEUTICS
ACADIA PARTNERSHIP STOKE THERAPEUTICS, page-8
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.27 |
Change
0.000(0.00%) |
Mkt cap ! $1.951B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 53 | $21.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.51 | 2114 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 15.320 |
2 | 212 | 15.310 |
8 | 1376 | 15.300 |
2 | 204 | 15.290 |
2 | 211 | 15.280 |
Price($) | Vol. | No. |
---|---|---|
15.380 | 99 | 3 |
15.390 | 177 | 2 |
15.400 | 259 | 3 |
15.410 | 380 | 4 |
15.420 | 646 | 4 |
Last trade - 10.04am 30/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable